Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA‐responsive cells in fragile X syndrome
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Disrupted metabotropic glutamate receptor 5 (mGluR5) signaling is implicated in many neuropsychiatric disorders, including autism spectrum disorder, found in fragile X syndrome (FXS). Here we report that intracellular calcium responses to the group I mGluR agonist (S)−3,5‐dihydroxyphenylglycine (DHPG) are augmented, and calcium‐dependent mGluR5‐mediated mechanisms alter the differentiation of neural progenitors in neurospheres derived from human induced pluripotent FXS stem cells and the brains of mouse model of FXS. Treatment with the mGluR5 antagonist 2‐methyl‐6‐(phenylethynyl)‐pyridine (MPEP) prevents an abnormal clustering of DHPG‐responsive cells that are responsive to activation of ionotropic receptors in mouse FXS neurospheres. MPEP also corrects morphological defects of differentiated cells and enhanced migration of neuron‐like cells in mouse FXS neurospheres. Unlike in mouse neurospheres, MPEP increases the differentiation of DHPG‐responsive radial glial cells as well as the subpopulation of cells responsive to both DHPG and activation of ionotropic receptors in human neurospheres. However, MPEP normalizes the FXS‐specific increase in the differentiation of cells responsive only to N‐methyl‐d‐aspartate (NMDA) present in human neurospheres. Exposure to MPEP prevents the accumulation of intermediate basal progenitors in embryonic FXS mouse brain suggesting that rescue effects of GluR5 antagonist are progenitor type‐dependent and species‐specific differences of basal progenitors may modify effects of MPEP on the cortical development. © 2016 Wiley Periodicals, Inc. Develop Neurobiol 77: 419–437, 2017
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
The Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475 · cited 1×
“Furthermore, intermediate progenitors may divide multiple times in primates, but predominantly undergo only one cell division to produce two neurons in rodents (Kriegstein and Alvarez-Buylla, 2009).”
BackgroundFMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 1×
“The rescue effects of genetic and pharmacologic manipulation with mGluR5 in Fmr1-KO mice indicate that mGluR5 signaling plays a central role in the pathophysiology of FXS (Huber et al., 2002; Bear et al., 2004; Dolen and Bear, 2008).”
BackgroundNeurogenic radial glia in the outer subventricular zone of human neocortex
Hansen, D. V., Lui, J. H., Parker, P. R. L., & Kriegstein, A. R. (2010) · Nature · doi:10.1038/nature08845 · Cited by 1,388 · cited 1×
“An increase in proliferative basal progenitors contributes to the neocortical enlargement and gyration in human brain (Hansen et al., 2010; Betizeau et al., 2013; LaMonica et al., 2013).”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 4×
“A protein-translation mGluR1/5- dependent form of long-term depression is increased in the hippocampus of Fmr1-KO mice (Huber et al., 2002; Nosyreva and Huber, 2006).”
BackgroundInfluentialCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · cited 3×
“A selective and systemically active antagonist of mGluR5, 2-methyl6-(phenylethynyl)-pyridine (MPEP), prevents the increased density of immature spines, susceptibility to audiogenic seizures, and excessive protein synthesis in Fmr1-KO mice (Yan et al., 2005; Dolen et al., 2007; de Vrij et al., 2008).”
BackgroundGasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725 · cited 1×
“To distinguish mGluR5-mediated processes, we blocked mGluR5 signaling in neural progenitors with MPEP, which is a potent antagonist of the mGluR5 subtype with no appreciable agonist or antagonist activity of mGluR1, group II or III mGluRs (Gasparini et al.,1999).”
BackgroundGlutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
Mattson, M. P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.005 · Cited by 640 · cited 1×
“Glutamate plays an important role in the control of neurogenesis (Brazel et al., 2005; Mattson, 2008; Nakamichi et al., 2009), and functional mGluR5s in neural progenitors are involved in regulating cell proliferation, survival, and differentiation (Di Giorgi Gerevini et al., 2004; Baskys et al.,…”
BackgroundGibson, J. R., Bartley, A. F., Hays, S. A., & Huber, K. M. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90752.2008 · Cited by 529 · cited 2×
“Defects in both inhibitory and excitatory transmission impair functional connectivi- ty and lead to hyperexcitability in the brains of these mice (Gibson et al., 2008; Pilpel et al., 2009; Zhang et al., 2014).”
BackgroundSuppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · cited 3×
“A selective and systemically active antagonist of mGluR5, 2-methyl6-(phenylethynyl)-pyridine (MPEP), prevents the increased density of immature spines, susceptibility to audiogenic seizures, and excessive protein synthesis in Fmr1-KO mice (Yan et al., 2005; Dolen et al., 2007; de Vrij et al., 2008).”
BackgroundFrom mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475
Betizeau, M., Cortay, V., Patti, D., Pfister, S., Gautier, E., Bellemin-Ménard, A., Afanassieff, M., Huissoud, C., Douglas, R. J., Kennedy, H., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.032 · Cited by 462
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370 · cited 3×
“Several studies report that targeting mGluR5 by MPEP improves the behavior (Bhakar et al., 2012), reduces audiogenic seizures (Yan et al., 2005), and normalizes the increased density of immature spines and excessive protein synthesis (Dolen et al., 2007; de Vrij et al., 2008) in Fmr1-KO mice.”
BackgroundRescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice
de Vrij, F. M. S., Levenga, J., van der Linde, H. C., Koekkoek, S. K., De Zeeuw, C. I., Nelson, D. L., Oostra, B. A., & Willemsen, R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.002 · Cited by 313 · cited 2×
“A selective and systemically active antagonist of mGluR5, 2-methyl6-(phenylethynyl)-pyridine (MPEP), prevents the increased density of immature spines, susceptibility to audiogenic seizures, and excessive protein synthesis in Fmr1-KO mice (Yan et al., 2005; Dolen et al., 2007; de Vrij et al., 2008).”
BackgroundBerry-Kravis, E., Des Portes, V., Hagerman, R., Jacquemont, S., Charles, P., Visootsak, J., Brinkman, M., Rerat, K., Koumaras, B., Zhu, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aab4109 · Cited by 270
Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice
Harlow, E. G., Till, S. M., Russell, T. A., Wijetunge, L. S., Kind, P., & Contractor, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.024 · Cited by 252 · cited 2×
“Maturation of glutamate receptor signaling is altered and the proportion of N-methyl-D-aspartate (NMDA)-only neurons is abnormally large at the close of the critical period in the somatosensory cortex of the Fmr1-KO mice (Dolen and Bear, 2008; Harlow et al., 2010).”
BackgroundFragile X and autism: intertwined at the molecular level leading to targeted treatments
Hagerman, R., Hoem, G., & Hagerman, P. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-12 · Cited by 247 · cited 2×
“FXS affects 1 in 4000 males and 1 in 6000 females worldwide, and is found in 2–6% of individuals with a diagnosis of autism spectrum disorder (Hagerman et al., 2010).”
BackgroundAltered differentiation of neural stem cells in fragile X syndrome
Castrén, M., Tervonen, T., Kärkkäinen, V., Heinonen, S., Castrén, E., Larsson, K., Bakker, C. E., Oostra, B. A., & Åkerman, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508995102 · Cited by 176 · cited 13×
“Mouse neural progenitors were propagated from the wall of lateral ventricles of E14 male embryos as previously described (Castren et al., 2005).”
BackgroundMethodSelf-citationiPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth
Doers, M. E., Musser, M. T., Nichol, R., Berndt, E. R., Baker, M., Gomez, T. M., Zhang, S.-C., Abbeduto, L., & Bhattacharyya, A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0030 · Cited by 165 · cited 1×
“…FMRP affects the pool of radial glia in the developing brain of Fmr1-KO mice and alters differentiation of FMRP-deficient neuronal pro- genitors (Castren et al., 2005; Tervonen et al., 2009; Callan and Zarnescu, 2011; Sheridan et al., 2011; Telias et al., 2013; Doers et al., 2014, Castren, 2016).”
BackgroundNew perspectives on the biology of fragile X syndrome
Wang, T., Bray, S. M., & Warren, S. T. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.002 · Cited by 116
Saffary, R., & Xie, Z. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4854-10.2011 · Cited by 103 · cited 2×
“A reduced pool of radial glia and an increased number of Tbr2-positive basal progenitors are shown in the embryonic cortex of Fmr1-KO mice (Castren et al., 2005; Tervonen, et al., 2009; Saffary and Xie, 2011).”
BackgroundPilpel, Y., Kolleker, A., Berberich, S., Ginger, M., Frick, A., Mientjes, E., Oostra, B. A., & Seeburg, P. H. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160929 · Cited by 102
Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome.
Tervonen, T. A., Louhivuori, V., Sun, X., Hokkanen, M.-E., Kratochwil, C. F., Zebryk, P., Castrén, E., & Castrén, M. L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.010 · Cited by 82 · cited 6×
“, 2006) accumulates in the ventricular zone/subventricular zone (VZ/SVZ) of the telencephalon in Fmr1-KO mouse brain at E17 (Castren et al., 2005; Tervonen et al., 2009).”
BackgroundMethodInfluentialSelf-citationA Subtype of Inhibitory Interneuron with Intrinsic Persistent Activity in Human and Monkey Neocortex
Wang, B., Yin, L., Zou, X., Ye, M., Liu, Y., He, T., Deng, S., Jiang, Y., Zheng, R., Wang, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.018 · Cited by 40 · cited 2×
“Recent studies revealed that higher order brain functions are linked with neuronal subpopulations present in primate but not in rat neo- cortex (Wang et al., 2015), and FXS iPS cell-derived neuronal subpopulations remain to be investigated after extended differentiation.”
BackgroundHeads‐up: New roles for the fragile X mental retardation protein in neural stem and progenitor cells
Callan, M. A., & Zarnescu, D. C. (2011) · genesis · doi:10.1002/dvg.20745 · Cited by 39 · cited 2×
“The absence of FMRP affects the pool of radial glia in the developing brain of Fmr1-KO mice and alters differentiation of FMRP-deficient neuronal progenitors (Castren et al., 2005; Tervonen et al., 2009; Callan and Zarnescu, 2011; Sheridan et al., 2011; Telias et al., 2013; Doers et al., 2014, Castren, 2016).”
BackgroundCortical neurogenesis in fragile X syndrome
Castrén, M. L. (2016) · Frontiers in Bioscience · doi:10.2741/s455 · Cited by 24
Self-citationAchuta, V. S., Rezov, V., Uutela, M., Louhivuori, V., Louhivuori, L., & Castrén, M. L. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3753-13.2014 · Cited by 22
Self-citation
Cited by
Demine, S., Schiavo, A. A., Marín-Cañas, S., Marchetti, P., Cnop, M., & Eizirik, D. L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1523-3 · Cited by 107
Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.
Brighi, C., Salaris, F., Soloperto, A., Cordella, F., Ghirga, S., de Turris, V., Rosito, M., Porceddu, P. F., D’Antoni, C., Reggiani, A., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03776-8 · Cited by 56
Utami, K. H., Skotte, N. H., Colaço, A. R., Yusof, N. A. B. M., Sim, B., Yeo, X. Y., Bae, H.-G., Garcia-Miralles, M., Radulescu, C. I., Chen, Q., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.005 · Cited by 47
Self-citationUrokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome
Peteri, U., Pitkonen, J., de Toma, I., Nieminen, O., Utami, K. H., Strandin, T. M., Corcoran, P., Roybon, L., Vaheri, A., Ethell, I., et al. (2021) · Glia · doi:10.1002/glia.24080 · Cited by 16
Self-citationAn iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis
Talvio, K., Wagner, V. A., Minkeviciene, R., Kirkwood, J. S., Kulinich, A. O., Umemori, J., Bhatia, A., Hur, M., Käkelä, R., Ethell, I. M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05147-9 · Cited by 8
Self-citation
Metadata
- Authors
- Achuta, V. S., Grym, H., Putkonen, N., Louhivuori, V., Kärkkäinen, V., Koistinaho, J., Roybon, L., & Castrén, M. L.
- Venue
- Developmental Neurobiology
- Publisher
- Wiley
- Published
- 2016-07-28
- Volume
- 77
- Issue
- 4
- Pages
- 438-453
- ISSN
- 1932-8451 (ISSN-L)
- 1932-846X
- OpenAlex
- W2498384398
- Cited by
- 44
- References
- 28
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.